UK considers coronavirus-free medical centers to get cancer treatments back on track

| April 29, 2020
doctors cancer patient articlelarge
Credit: iStock
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Thousands of cancer patients in the UK have had their treatment stopped or delayed because of COVID-19, and with pressures mounting on the health service, Cancer Research UK calls for widespread testing to prevent unnecessary cancer deaths.

In some cases, already overstretched NHS staff are being directed away from cancer care, towards caring for COVID-19 patients. And in other cases, where a cancer patient might have a weakened immune system as a result of cancer treatment, it may not be safe for them to go to hospital.

The NHS in England is developing ‘COVID-free’ centres and hospitals which will be the key to ensuring that the most urgent cancer patients can receive their treatment quickly, but this will only be possible with widescale and frequent testing of NHS staff and patients.

Related article:  Another COVID-19 casualty: 'Major delays' for gene therapy trials for rare diseases

Although some patients are being tested for COVID-19, testing in some areas is reserved for those who are seriously ill. The concern is that a number of people with the virus may be infectious to others before they show symptoms, so for a hospital to be truly safe to treat cancer patients, we need rapid testing available for all staff and patients, whether showing symptoms of COVID-19 or not, occurring on a routine and repetitive basis.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend